Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: A new treatment paradigm

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 593-598

  Urba, Susan ^a   Wolf, Gregory ^a   Eisbruch, Avraham ^a   Worden, Francis ^a   Lee, Julia ^a   Bradford, Carol ^a   Teknos, Theodoros ^a   Chepeha, Douglas ^a   Prince, Mark ^a   Hogikyan, Norman ^a   Taylor, Jeremy ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HISTOLOGY; HUMAN; KIDNEY DISEASE; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NEUTROPENIA; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION NECROSIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; LARYNX TUMOR; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; NECROSIS; PATHOLOGY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; REMISSION; SALVAGE THERAPY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECROSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644846431     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.2047     Document Type: Article

References (19)

1. Schuller DE, Metch B, Stein D, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: Final Report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988
2. Jacobs C, Goffinet DR: Goffinett L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 60:1178-1183, 1987
3. Hong WK, Bronner RH, Amato DA, et al: Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56:1242-1245, 1985
4. Ensley JF, Jacobs JR, Weaver A, et al: Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811-814, 1984
5. Spaulding MB, Fischer SG, Wolf GT, et al: Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599, 1994
6. The Department of Veterans Affairs' Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
7. Lefebrve J, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899/1996
8. Brizel D, Albers N, Fisher S, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
9. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
10. Cooper JS, Pajak TF, Forastiere AF, et al: Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med 350:1937-1944, 2004
11. Bernier J, Domenge C, Ozsahin M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952, 2004
12. Eisbruch A, Thornton AF, Urba S, et al: Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. J Clin Oncol 14:2322-2330, 1996
13. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988
14. Eisbruch A, Marsh LH, Martel MK, et al: Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 41:559-568, 1998
15. Franch G, Minatel E, Gobitt, et al: Radiotherapy for patients with early-stage glottic carcinoma. Cancer 98:765-772, 2003
16. De Santo LW: T3 glottic cancer: Options and consequences of the options. Laryngoscope 94:1311-1315, 1984
17. Pfister DG, Strong E, Harrison L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but respectable head and neck cancer. J Clin Oncol 9:850-859, 1991
18. Shirinian MH, Weber RG, Lippman SM, et al: Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience. Head Neck 16:39-44, 1994
19. Weber RS, Berkey BA, Forastiere AF, et al: Outcome of salvage total laryngectomy following organ preservation therapy: The Radiation Therapy Oncology Group Trial 91-11. Arch Otolaryngol Head Neck Surg 129:44-49, 2003